The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2020

Filed:

Aug. 29, 2019
Applicant:

Avixgen Inc., Seoul, KR;

Inventors:

Min Jung Kim, Seoul, KR;

Jun Sub Choi, Yongin-si, KR;

Hye Cheong Koo, Gwangmyeong-si, KR;

Yi Yong Baek, Goyang-si, KR;

Assignee:

AVIXGEN INC., Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/427 (2006.01); A61P 31/18 (2006.01); A61K 31/52 (2006.01); A61K 31/675 (2006.01); A61K 31/7068 (2006.01); A61K 31/7076 (2006.01);
U.S. Cl.
CPC ...
A61K 31/427 (2013.01); A61P 31/18 (2018.01); A61K 31/52 (2013.01); A61K 31/675 (2013.01); A61K 31/7068 (2013.01); A61K 31/7076 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for preventing or treating AIDS, comprising a rhodanine derivative and a nucleoside reverse transcriptase inhibitor. A complex composition of the present invention exhibits a synergistic effect in terms of anti-HIV activity as compared with a case where each of the compounds is used as a single drug. Thus, the composition provides sufficient anti-HIV activity and exhibits an excellent effect of decreasing side effects such as toxicity even in a case where each compound is administered in a small amount. Accordingly, the present invention is expected to greatly contribute to treatment of AIDS patients.


Find Patent Forward Citations

Loading…